Results 281 to 290 of about 115,960 (309)
Some of the next articles are maybe not open access.
E Rosette Formation in B Cell Chronic Lymphocytic Leukemia
Acta Haematologica, 2009We describe a patient with B cell chronic lymphocytic leukemia whose B lymphocytes showed the capacity to form rosettes with sheep red blood cells during prolymphocytoid transformation of the disease. In this case, rosette formation was found to be related to the presence of the classic E rosette receptor since the leukemic cells were recognized by the
MUSOLINO, Caterina +7 more
openaire +4 more sources
Ibrutinib in chronic lymphocytic leukemia and B cell malignancies
Leukemia & Lymphoma, 2013Recent clinical data suggest remarkable activity of ibrutinib, the first-in-class covalent inhibitor of Bruton's tyrosine kinase (BTK), in chronic lymphocytic leukemia (CLL), as well as excellent activity in other B cell malignancies, including in particular mantle cell lymphoma and Waldenstrom macroglobulinemia.
openaire +2 more sources
Antigen Receptor Function in Chronic Lymphocytic Leukemia B Cells
Leukemia & Lymphoma, 1996Functional studies revealed that two groups of B chronic lymphocytic leukemia (B-CLL) can be distinguished based on their capacity to mount a proliferative response following B-cell antigen receptor (BCR) cross-linking. The molecular basis for the functional distinction between these B-CLL groups most probably resides within or proximal to the BCR ...
Lankester, A. C. +4 more
openaire +3 more sources
B Cell Chronic Lymphocytic Leukemia
Annals of the New York Academy of Sciences, 2003RAJENDRA N. DAMLE +9 more
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Ca-A Cancer Journal for Clinicians, 2020Enrica Marchi
exaly